Frae Wikipedia
Jump to navigation Jump to search
An image o the amphetamine compoond
A 3d image o the amphetamine compoond
Clinical data
AHFS/ entry
Leecence data
  • US: C (Risk nae ruled oot)
Pheesical: none
Psychological: moderate
Routes o
Medical: oral, nasal inhalation
Recreational: oral, nasal inhalation, insufflation, rectal, intravenous
ATC code
Legal status
Legal status
Pharmacokinetic data
Bioavailability Rectal 95–100%; Oral 75–100%[1]
Protein bindin 15–40%[2]
Metabolism CYP2D6,[3] DBH,[4][5][6] FMO3,[7][8] XM-ligase,[9] an ACGNAT[10]
Onset o action Immediate
Biological hauf-life D-amph:9–11h;[3][11] L-amph:11–14h[3][11]
Excretion Renal; pH-dependent range: 1–75%[3]
Synonyms α-methylphenethylamine
CAS Nummer
PubChem CID
PDB ligand
ECHA InfoCard 100.005.543
Chemical and physical data
Formula C9H13N
Molar mass 135.2084 g/mol
3D model (Jmol)
Density 0.9±0.1 g/cm3
Meltin pynt 11.3 °C (52.3 °F) [12]
Bylin pynt 203 °C (397 °F) [13]

Amphetamine (pronunciation: Listeni/æmˈfɛtəmn/; contractit frae alphamethylphenethylamine) is a potent central nervous seestem (CNS) stimulant o the phenethylamine class that is uised in the treatment o attention deficit hyperactivity disorder (ADHD) an narcolepsy.

References[eedit | eedit soorce]

  1. "Pharmacology". Dextroamphetamine. DrugBank. University of Alberta. 8 February 2013. Retrieved 5 November 2013. 
  2. "Pharmacology". Amphetamine. DrugBank. University of Alberta. 8 February 2013. Retrieved 5 November 2013. 
  3. 3.0 3.1 3.2 3.3 "Adderall XR Prescribing Information" (PDF). United States Food and Drug Administration. Shire US Inc. December 2013. pp. 12–13. Retrieved 30 December 2013. 
  4. Lemke TL, Williams DA, Roche VF, Zito W (2013). Foye's Principles of Medicinal Chemistry (7th ed.). Philadelphia, USA: Wolters Kluwer Health/Lippincott Williams & Wilkins. p. 648. ISBN 9781609133450. Alternatively, direct oxidation of amphetamine by DA β-hydroxylase can afford norephedrine. 
  5. Taylor KB (January 1974). "Dopamine-beta-hydroxylase. Stereochemical course of the reaction" (PDF). J. Biol. Chem. 249 (2): 454–458. PMID 4809526. Retrieved 6 November 2014. Dopamine-β-hydroxylase catalyzed the removal of the pro-R hydrogen atom and the production of 1-norephedrine, (2S,1R)-2-amino-1-hydroxyl-1-phenylpropane, from d-amphetamine. 
  6. Horwitz D, Alexander RW, Lovenberg W, Keiser HR (May 1973). "Human serum dopamine-β-hydroxylase. Relationship to hypertension and sympathetic activity". Circ. Res. 32 (5): 594–599. doi:10.1161/01.RES.32.5.594. PMID 4713201. Subjects with exceptionally low levels of serum dopamine-β-hydroxylase activity showed normal cardiovascular function and normal β-hydroxylation of an administered synthetic substrate, hydroxyamphetamine. 
  7. Krueger SK, Williams DE (June 2005). "Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism". Pharmacol. Ther. 106 (3): 357–387. doi:10.1016/j.pharmthera.2005.01.001. PMC 1828602Freely accessible. PMID 15922018. 
  8. Cashman JR, Xiong YN, Xu L, Janowsky A (March 1999). "N-oxygenation of amphetamine and methamphetamine by the human flavin-containing monooxygenase (form 3): role in bioactivation and detoxication". J. Pharmacol. Exp. Ther. 288 (3): 1251–1260. PMID 10027866. 
  9. "Substrate/Product". butyrate-CoA ligase. BRENDA. Technische Universität Braunschweig. Retrieved 7 May 2014. 
  10. "Substrate/Product". glycine N-acyltransferase. BRENDA. Technische Universität Braunschweig. Retrieved 7 May 2014. 
  11. 11.0 11.1 "Adderall IR Prescribing Information" (PDF). United States Food and Drug Administration. Barr Laboratories, Inc. March 2007. pp. 4–5. Retrieved 2 November 2013. 
  12. "Properties: Predicted – EP|Suite". Amphetamine. Chemspider. Retrieved 6 November 2013. 
  13. "Chemical and Physical Properties". Amphetamine. PubChem Compound. National Center for Biotechnology Information. Retrieved 13 October 2013.